Search Results - "Morita, S."

Exploring deep microbial life in coal-bearing sediment down to ∼2.5 km below the ocean floor by Inagaki, F., Hinrichs, K.-U., Kubo, Y., Bowles, M. W., Heuer, V. B., Hong, W.-L., Hoshino, T., Ijiri, A., Imachi, H., Ito, M., Kaneko, M., Lever, M. A., Lin, Y.-S., Methé, B. A., Morita, S., Morono, Y., Tanikawa, W., Bihan, M., Bowden, S. A., Elvert, M., Glombitza, C., Gross, D., Harrington, G. J., Hori, T., Li, K., Limmer, D., Liu, C.-H., Murayama, M., Ohkouchi, N., Ono, S., Park, Y.-S., Phillips, S. C., Prieto-Mollar, X., Purkey, M., Riedinger, N., Sanada, Y., Sauvage, J., Snyder, G., Susilawati, R., Takano, Y., Tasumi, E., Terada, T., Tomaru, H., Trembath-Reichert, E., Wang, D. T., Yamada, Y.

“…Microbial life inhabits deeply buried marine sediments, but the extent of this vast ecosystem remains poorly constrained. Here we provide evidence for the…”
Get full text

Nonstructural Carbohydrate Content in the Stem at Full Heading Contributes to High Performance of Ripening in Heat-Tolerant Rice Cultivar Nikomaru by Morita, S, Nakano, H

“…Rice (Oryza sativa L.) grain yields in western Japan have recently decreased as a result of higher temperatures during ripening. The improvement of rice…”
Get full text

Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer by Yoshioka, H., Shimokawa, M., Seto, T., Morita, S., Yatabe, Y., Okamoto, I., Tsurutani, J., Satouchi, M., Hirashima, T., Atagi, S., Shibata, K., Saito, H., Toyooka, S., Yamamoto, N., Nakagawa, K., Mitsudomi, T.

“…Primary analysis of the phase III study WJTOG 3405 demonstrated superiority of progression-free survival (PFS) for gefitinib (G) in patients treated with the…”
Get full text

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) by Inoue, A., Kobayashi, K., Maemondo, M., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., Fujita, Y., Okinaga, S., Hirano, H., Yoshimori, K., Harada, T., Saijo, Y., Hagiwara, K., Morita, S., Nukiwa, T.

“…NEJ002 study, comparing gefitinib with carboplatin (CBDCA) and paclitaxel (PTX; Taxol) as the first-line treatment for advanced non-small cell lung cancer…”
Get full text

Lipoarabinomannan mediates localized cell wall integrity during division in mycobacteria by Sparks, Ian L., Kado, Takehiro, Prithviraj, Malavika, Nijjer, Japinder, Yan, Jing, Morita, Yasu S.

“…The growth and division of mycobacteria, which include clinically relevant pathogens, deviate from that of canonical bacterial models. Despite their…”
Get full text

Plat-E : an efficient and stable system for transient packaging of retroviruses by MORITA, S, KOJIMA, T, KITAMURA, T

“…A potent retrovirus packaging cell line named Platinum-E (Plat-E) was generated based on the 293T cell line. Plat-E is superior to existing packaging cell…”
Get full text

Inositol acylation of phosphatidylinositol mannosides: a rapid mass response to membrane fluidization in mycobacteria by Nguyen, Peter P., Kado, Takehiro, Prithviraj, Malavika, Siegrist, M. Sloan, Morita, Yasu S.

“…Mycobacteria share an unusually complex, multilayered cell envelope, which contributes to adaptation to changing environments. The plasma membrane is the…”
Get full text

Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle by Ishikawa, Eri, Ishikawa, Tetsuaki, Morita, Yasu S, Toyonaga, Kenji, Yamada, Hisakata, Takeuchi, Osamu, Kinoshita, Taroh, Akira, Shizuo, Yoshikai, Yasunobu, Yamasaki, Sho

“…Tuberculosis remains a fatal disease caused by Mycobacterium tuberculosis, which contains various unique components that affect the host immune system…”
Get full text

The efficacy of lidocaine to prevent laryngospasm in children: a systematic review and meta‐analysis by Mihara, T., Uchimoto, K., Morita, S., Goto, T.

“…Summary The purpose of this meta‐analysis was to determine the efficacy of lidocaine in preventing laryngospasm during general anaesthesia in children. An…”
Get full text

Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer by Hayashi, H., Okamoto, I., Morita, S., Taguri, M., Nakagawa, K.

“…Given the growing number of drugs available for non-small-cell lung cancer (NSCLC), an effect of first-line chemotherapy on overall survival (OS) might be…”
Get full text

Detergent-induced quantitatively limited formation of diacyl phosphatidylinositol dimannoside in Mycobacterium smegmatis by Kitzmiller, Claire E., Cheng, Tan-Yun, Prandi, Jacques, Sparks, Ian L., Moody, D. Branch, Morita, Yasu S.

“…Mycobacterial plasma membrane, together with the peptidoglycan-arabinogalactan cell wall and waxy outer membrane, creates a robust permeability barrier against…”
Get full text

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G) by Yamazaki, K., Nagase, M., Tamagawa, H., Ueda, S., Tamura, T., Murata, K., Eguchi Nakajima, T., Baba, E., Tsuda, M., Moriwaki, T., Esaki, T., Tsuji, Y., Muro, K., Taira, K., Denda, T., Funai, S., Shinozaki, K., Yamashita, H., Sugimoto, N., Okuno, T., Nishina, T., Umeki, M., Kurimoto, T., Takayama, T., Tsuji, A., Yoshida, M., Hosokawa, A., Shibata, Y., Suyama, K., Okabe, M., Suzuki, K., Seki, N., Kawakami, K., Sato, M., Fujikawa, K., Hirashima, T., Shimura, T., Taku, K., Otsuji, T., Tamura, F., Shinozaki, E., Nakashima, K., Hara, H., Tsushima, T., Ando, M., Morita, S., Boku, N., Hyodo, I.

“…FOLFIRI and FOLFOX have shown equivalent efficacy for metastatic colorectal cancer (mCRC), but their comparative effectiveness is unknown when combined with…”
Get full text

C-Type Lectin Receptor DCAR Recognizes Mycobacterial Phosphatidyl-Inositol Mannosides to Promote a Th1 Response during Infection by Toyonaga, Kenji, Torigoe, Shota, Motomura, Yoshitomo, Kamichi, Takane, Hayashi, Jennifer M., Morita, Yasu S., Noguchi, Naoto, Chuma, Yasushi, Kiyohara, Hideyasu, Matsuo, Kazuhiro, Tanaka, Hiroshi, Nakagawa, Yoshiko, Sakuma, Tetsushi, Ohmuraya, Masaki, Yamamoto, Takashi, Umemura, Masayuki, Matsuzaki, Goro, Yoshikai, Yasunobu, Yano, Ikuya, Miyamoto, Tomofumi, Yamasaki, Sho

“…Phosphatidyl-inositol mannosides (PIM) are glycolipids unique to mycobacteria and other related bacteria that stimulate host immune responses and are…”
Get full text

Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial) by Misawa, K., Mochizuki, Y., Sakai, M., Teramoto, H., Morimoto, D., Nakayama, H., Tanaka, N., Matsui, T., Ito, Y., Ito, S., Tanaka, K., Uemura, K., Morita, S., Kodera, Y.

“…Background A survival benefit of extensive intraoperative peritoneal lavage (EIPL) has been reported in patients with gastric cancer with positive peritoneal…”
Get full text

VEGF-dependent continuous angiogenesis in the median eminence of adult mice by Morita, S., Ukai, S., Miyata, S.

“…Brain vasculature forms the blood–brain barrier (BBB) that restricts the movement of molecules between the brain and blood, but the capillary of the median…”
Get full text

Total ankle arthroplasty incorporating a total talar prosthesis: a comparative study against the standard total ankle arthroplasty by Kurokawa, H, Taniguchi, A, Morita, S, Takakura, Y, Tanaka, Y

“…AimsTotal ankle arthroplasty (TAA) has become the most reliable surgical solution for patients with end-stage arthritis of the ankle. Aseptic loosening of the…”
Get full text

Novel six-axis robot kinematic model with axis-to-axis crosstalk by Ibaraki, S., Fukuda, K., Alam, M.M., Morita, S., Usuki, H., Otsuki, N., Yoshioka, H.

“…Conventionally, the volumetric error compensation of six-axis robots is mostly based on a kinematic model with position and orientation errors of the rotary…”
Get full text

Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902 by Sugawara, S., Oizumi, S., Minato, K., Harada, T., Inoue, A., Fujita, Y., Maemondo, M., Yoshizawa, H., Ito, K., Gemma, A., Nishitsuji, M., Harada, M., Isobe, H., Kinoshita, I., Morita, S., Kobayashi, K., Hagiwara, K., Kurihara, M., Nukiwa, T.

“…EGFR-TKI therapy produces a dramatic clinical response in patients with NSCLC harboring EGFR mutation. However, clinical outcomes should be improved further in…”
Get full text

A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype by Hirai, K., Shirai, T., Suzuki, M., Akamatsu, T., Suzuki, T., Hayashi, I., Yamamoto, A., Akita, T., Morita, S., Asada, K., Tsuji, D., Inoue, K., Itoh, K.

“…Summary Background Asthma and chronic obstructive pulmonary disease (COPD) are heterogeneous diseases. The phenotypes that have clinical features of both…”
Get full text

Peptidoglycan precursor synthesis along the sidewall of pole-growing mycobacteria by García-Heredia, Alam, Pohane, Amol Arunrao, Melzer, Emily S, Carr, Caleb R, Fiolek, Taylor J, Rundell, Sarah R, Lim, Hoong Chuin, Wagner, Jeffrey C, Morita, Yasu S, Swarts, Benjamin M, Siegrist, M Sloan

“…Rod-shaped mycobacteria expand from their poles, yet d-amino acid probes label cell wall peptidoglycan in this genus at both the poles and sidewall. We sought…”
Get full text